This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Apr;118(4):792; author reply 792-3.

doi: 10.1016/j.ophtha.2011.01.012.

Rituximab for thyroid eye disease

Sang-Rog Oh, Ayelet Priel, Leah Levi, David B Granet, Bobby S Korn, Don O Kikkawa

PMID: 21459230
DOI: 10.1016/j.ophtha.2011.01.012

Comment

Rituximab for thyroid eye disease

Sang-Rog Oh et al. Ophthalmology. 2011 Apr.

. 2011 Apr;118(4):792; author reply 792-3.

doi: 10.1016/j.ophtha.2011.01.012.

Authors

Sang-Rog Oh, Ayelet Priel, Leah Levi, David B Granet, Bobby S Korn, Don O Kikkawa

PMID: 21459230
DOI: 10.1016/j.ophtha.2011.01.012

No abstract available

PubMed Disclaimer

Comment on

Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.
Khanna D, Chong KK, Afifiyan NF, Hwang CJ, Lee DK, Garneau HC, Goldberg RA, Darwin CH, Smith TJ, Douglas RS. Khanna D, et al. Ophthalmology. 2010 Jan;117(1):133-139.e2. doi: 10.1016/j.ophtha.2009.05.029. Epub 2009 Oct 8. Ophthalmology. 2010. PMID: 19818507 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information